Humira

Date: 03/21/25

Heritage Health (Medicaid):

Nebraska Medicaid has recently designated a biosimilar of Humira as preferred on the Nebraska Medicaid Preferred Drug List. The Boehringer Ingelheim Pharmaceuticals biosimilar, adalimumab-adbm, is now at preferred status and does not require a trial of a Humira product before approval. The Nebraska Medicaid PDL, as well as other formulary resources can be found on the Nebraska Total Care Pharmacy provider website. For more information on prescribing biosimilars, please visit the FDA Biosimilars.